Advertisement
Advertisement
NBP
N
NovaBridge Biosciences - ADR
3.38
USDSponsored
-0.04
-1.17%
Feb 05, 11:49 UTC -5
Open
NBP Earnings Reports
Positive Surprise Ratio
NBP beat 3 of 6 last estimates.
50%
Next Report
Date of Next Report
Apr 01, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.05
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/-37.50%
NovaBridge Biosciences - ADR earnings per share and revenue
On --, NBP reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.05 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.82
Actual
$11.44
Surprise
+5.65%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
Mesoblast Limited - ADR
Report Date
Jan 29, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.07
Surprise
-5.90%
AYTU BioPharma, Inc. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
-$0.61
Actual
-$1.05
Surprise
-71.57%
FAQ
What were NovaBridge Biosciences - ADR's earnings and revenue for the latest quarter Q-- --?
For Q-- --, NovaBridge Biosciences - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to NovaBridge Biosciences - ADR's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is NovaBridge Biosciences - ADR expected to report next?
The next earning report is scheduled for Apr 01, 2026.
What are the forecasts for NovaBridge Biosciences - ADR's next earnings report?
Based on 7
analysts, NovaBridge Biosciences - ADR is expected to report EPS of -$0.05 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement